This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Aug 25;95(8):e1114-e1116.

doi: 10.1212/WNL.0000000000010302.

Initial highly effective therapy for MS: A strong start

Mitchell T Wallin

PMID: 32839302
DOI: 10.1212/WNL.0000000000010302

Comment

Initial highly effective therapy for MS: A strong start

Mitchell T Wallin. Neurology. 2020.

. 2020 Aug 25;95(8):e1114-e1116.

doi: 10.1212/WNL.0000000000010302.

Author

Mitchell T Wallin

PMID: 32839302
DOI: 10.1212/WNL.0000000000010302

No abstract available

PubMed Disclaimer

Comment on

Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.
Buron MD, Chalmer TA, Sellebjerg F, Barzinji I, Danny B, Christensen JR, Christensen MK, Hansen V, Illes Z, Jensen HB, Kant M, Papp V, Petersen T, Prakash S, Rasmussen PV, Schäfer J, Theódórsdóttir Á, Weglewski A, Sorensen PS, Magyari M. Buron MD, et al. Neurology. 2020 Aug 25;95(8):e1041-e1051. doi: 10.1212/WNL.0000000000010135. Epub 2020 Jul 7. Neurology. 2020. PMID: 32636328

Publication types

Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information